Hongqi Pharmaceutical
HONGQI PHARMACEUTICAL
Cherish life, pay attention to health.
CHERISH LIFE CARE ABOUT HEALTH
Shanrong Breaks Through and Grows | Shenyang Hongqi Pharmaceutical Successfully Held Its 2023 Annual Work Conference
Category:
Company News
Author:
Source:
Add time:2023-02-23 08:38
On January 16, 2023, Shenyang Hongqi Pharmaceutical Co., Ltd. successfully held its 2023 annual work conference. Centered around the theme “Integration, Breakthrough, Growth,” the meeting comprehensively reviewed and summarized the company’s performance in 2022 and systematically planned and deployed key priorities for 2023. All management personnel attended the conference at the main venue in Shenyang, as well as at branch venues in Hainan and Xuzhou, and via online participation.
Interpretation of Subject Terms
Shanrong
Good at shouldering social responsibility in tuberculosis prevention and control, and deeply cultivating its core strengths. Skilled at pioneering new frontiers and developing product lines in emerging areas.
Integration: seamlessly connecting and consolidating resources from all sectors to foster both internal and external ecosystem collaboration.
Breakthrough
Break through in all areas of public health and build end-to-end tuberculosis prevention and control services.
Break through cost pressures, reduce costs and boost efficiency, and establish a cost advantage in the CMO business.
Take the long way
Maintain the “dual‑engine” development strategy of marketing and R&D, ensuring steady and resilient growth.
Maintain learning motivation and drive continuous employee skill development.
Introduction of Newly Appointed Mid- and Senior-Level Managers
Thematic Forum: Planning and Pathways for “Breakthrough”
External guest
Li Mei, President of Jiangsu Wanbang Pharmaceutical Marketing Co., Ltd., delivered a presentation titled “Retail Development Insights,” providing an in-depth overview of the evolving pharmaceutical retail landscape in the new environment and sharing Wanbang Pharmaceutical’s strategic brand positioning as well as its team culture.
General Manager’s Work Report
General Manager Liu Wei provided a comprehensive review and summary of the company’s 2022 operations, outlined the 2023 business objectives and work plan, and conducted a detailed analysis of the key challenges to be addressed in 2023 along with corresponding solutions, thereby setting a clear direction for the year ahead. Mr. Liu emphasized that all employees must keep “goals” firmly in mind, treat “execution” as an ironclad principle, and embrace “accountability” as a matter of personal commitment, focusing their efforts and uniting their strengths to ensure that every task is carried out thoroughly, meticulously, and effectively, thus collectively driving the company toward the achievement of its performance targets.
Chairman’s Address
' fill='%23FFFFFF'%3E%3Crect x='249' y='126' width='1' height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Chairman Yang Bo fully commended all employees for their achievements in 2022. From a holistic and strategic perspective, he eloquently and profoundly articulated the thematic essence of “Shanrong: Breakthroughs, Sustained Growth,” while clearly defining the specific objectives of our future strategic plan. Chairman Yang noted that, with the relaxation of pandemic‑related policies, the economic outlook for 2023 is expected to improve across the board. He urged all members of the Hongqi team to adapt to the evolving demands of each stage of development, proactively seek new breakthroughs and opportunities, and remain firmly focused on the core goal of “tenfold growth over ten years” and the strategic roadmap of “one core, two wings, dual‑engine drive.” By continuously building core competitive advantages and sustainable growth drivers, we will achieve endogenous expansion, external scaling, and integrated, exponential growth. He expressed his hope that all colleagues will work together in unity, grow and reap rewards alongside the company, and inject inexhaustible momentum into realizing our first RMB 1 billion target by 2025.
The road ahead is long and arduous, the task both heavy and far-reaching; only by striving for every small achievement can we go far. These solemn vows are the clarion call for the people of Hongqi to set sail once again in pursuit of our dreams; and relentless perseverance will surely be our most resounding response. In the new year, let us, the people of Hongqi, remain steadfast in our confidence and forge ahead with courage and determination!
Meeting venue
Mou Bin, General Manager of Shenyang Hongqi Pharmaceutical and Deputy General Manager of Shenyang Hongqi Pharmaceutical: Steeling Our Forces and Readying Ourselves for Action
Deputy General Manager and Chief Financial Officer Li Feng: Integrating Operations and Finance to Empower Sustainable Growth
BD Director Liu Yaxia: Refinement, Breakthrough, Evolution
Gu Qiqiao, Director of Human Resources and Head of the HR Department: “A journey of a thousand miles begins with a single step; only culture ensures enduring vitality.” — 2022 HR Annual Report and Future Outlook
Guest Hu Zhenbao, Senior Marketing Director at Jiangsu Wanbang Pharmaceutical: Brand Management Insights from Jieshile
Marketing HR Manager Chen Hui: Hosted the introduction of newly appointed mid- and senior-level managers and the signing of responsibility agreements for business performance indicators.
Process Management Manager Shi Quan: Achieving Efficiency Through Flexibility—Introduction to the Process and System Optimization Project
